Related Experiment Videos
Artificial Intelligence in Febrile Neutropenia: From Risk Scores to Real-Time Clinical Decision Support
Kunj R Ghantiwala1,2, Ruchik Kevadiya3, Pradeep Pentapurthy4,5
1Medicine, Gujarat Medical Education and Research Society (G.M.E.R.S.) Medical College, Navsari, IND.
Cureus
|August 9, 2026
Summary
Artificial intelligence (AI) offers evolving support for managing febrile neutropenia in oncology. AI tools show potential for real-time clinical decision support, improving patient risk assessment and care management.
Area of Science:
- Oncology
- Clinical Decision Support
- Artificial Intelligence
Background:
- Febrile neutropenia is a critical oncological complication requiring prompt management.
- Traditional risk assessment tools for febrile neutropenia have limitations in dynamic clinical settings.
- Artificial intelligence (AI) is emerging as a valuable tool to enhance patient care.